0.285
0.93%
0.0048
Universe Pharmaceuticals Inc stock is traded at $0.285, with a volume of 220.88K.
It is up +0.93% in the last 24 hours and up +29.78% over the past month.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
See More
Previous Close:
$0.2802
Open:
$0.2802
24h Volume:
220.88K
Relative Volume:
0.07
Market Cap:
$6.59M
Revenue:
$32.31M
Net Income/Loss:
$-6.16M
P/E Ratio:
-0.0925
EPS:
-3.08
Net Cash Flow:
$1.08M
1W Performance:
-9.21%
1M Performance:
+29.78%
6M Performance:
-86.85%
1Y Performance:
-74.29%
Universe Pharmaceuticals Inc Stock (UPC) Company Profile
Universe Pharmaceuticals Inc Stock (UPC) Latest News
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health Pharmaceutical Co., Ltd. to Develop its Digital Marketing and Sales on E-Commerce Platforms - Marketscreener.com
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewswire
Universe Pharmaceuticals faces Nasdaq delisting over share price - Investing.com India
Universe Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd - Marketscreener.com
Universe Pharmaceuticals INC Attends West Lake Forum and Exhibits Upgraded Products - Marketscreener.com
Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine - Marketscreener.com
Nova Scotia election: Liberals promise to establish inquiry into illegal fishing - Yahoo Canada Finance
Zefiro Methane Corp. Founder & CEO Interviewed on Live Yahoo! Finance Broadcast - The Manila Times
Universe Pharmaceuticals faces Nasdaq delisting over share price By Investing.com - Investing.com UK
Middle East Partnership Opens Doors For Local Businesses To New Markets - Universe News Network
Faraday Future Intelligent Electric Inc (FFIE): Worth A Small Bite At $2.24 - Stocks Register
Upward Trajectory: Universe Pharmaceuticals INC (UPC) Posts a Gaine, Closing at 0.44 - The Dwinnex
Market cap of Universe Pharmaceuticals INC [UPC] reaches 10.38M – now what? - The DBT News
How does UPC’s price to cash per share ratio compare in the market? - US Post News
Universe Pharmaceuticals INC (UPC) Stock: Navigating a Year of Volatility - The InvestChronicle
Universe Pharmaceuticals INC [UPC] fell -87.86% so far this year. What now? - The DBT News
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Universe Pharmaceuticals appoints new auditor By Investing.com - Investing.com South Africa
Universe Pharmaceuticals appoints new auditor - Investing.com India
Universe Pharmaceuticals Confirms Financial Filing Accuracy - TipRanks
Universe Pharmaceuticals INC. CIK Number: 0001809616 Form 6 K - Marketscreener.com
Universe Pharmaceuticals INC (UPC) Stock: A Year of Highs and Lows - The InvestChronicle
Examining Universe Pharmaceuticals INC (UPC) more closely is necessary - US Post News
Daily Market Movement: Universe Pharmaceuticals INC (UPC) Sees a -1.85 Decrease, Closing at 0.22 - The Dwinnex
Morgan Stanley makes changes to its growth portfolio: 2 stocks added and 2 removed - Investing.com
Wall Street today: US stocks trade higher as investors re-evaluate big Fed rate cut potential, Intel Corp. gains 1.83% - MSN
Universe Pharmaceuticals INC’s Banking’s 100-Day Moving Average at 2.6750: Will the Stock Break Through? - The InvestChronicle
Universe Pharmaceuticals (NYSE:UPC) Shares Down 10.1% - Defense World
Universe Pharmaceuticals stock hits 52-week low at $0.21 - Investing.com
Closing Bell Recap: Universe Pharmaceuticals INC (UPC) Ends at 0.23, Reflecting a -2.90 Downturn - The Dwinnex
Investing in Universe Pharmaceuticals INC (UPC) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
CNS Pharma (NASDAQ:CNSP) Stock Quotes, Forecast and News Summary - Benzinga
TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga
Universe Pharmaceuticals Secures Strong Shareholder Backing - TipRanks
Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge - Simply Wall St
What Did We Find About Insider Trading At Serve Robotics Inc (NASDAQ: SERV)? - Stocks Register
How Are Things Looking For Universe Pharmaceuticals INC (NASDAQ: UPC) For The Short Term? - Stocks Register
Interior Designers Highlight Top Seasonal Decor Shifts For 2024 - Universe News Network
Jefferies Financial Group Boosts United Therapeutics (NASDAQ:UTHR) Price Target to $432.00 - Defense World
A Tale of Resilience: Universe Pharmaceuticals INC Amid Stock Market Turbulence - The InvestChronicle
What was Universe Pharmaceuticals INC (UPC)’s performance in the last session? - US Post News
Gaining Ground: Universe Pharmaceuticals INC (UPC) Closes Lower at 0.29, Down -13.83 - The Dwinnex
Rhumbline Advisers Grows Stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World
Universe Pharmaceuticals Inc Stock (UPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):